newsfilter
← Latest News
GlobeNewswire·

Oculis Reports Q3 2025 Financial Results and Provides Company Update

Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) following positive FDA